Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age

It was suggested that glucose metabolism and body fat content depend on serum levels of 25-hydroxyvitamin D [25(OH)D]. We studied 320 healthy women at late reproductive age of 40 to 52 years old (mean age 46.1±4.5) from St. Petersburg (North-West region of Russia). 25(OH)D levels were from 19.4 to 134.0 nMol/L (mean 52.9±22.7). Vitamin D deficiency (lower than 50 nMol/L) and insufficiency (50-75 nMol/L) was revealed in 59.1% and 27.8% of women, respectively. The study showed that low 25(OH)D levels were associated with obesity (r=-0.35, p<0.01), increased plasma glucose levels after OGTT (r=-0.31, p<0.01) and decreased insulin sensitivity index (r=-0.28, p<0.01). We found that 25(OH)D levels below 50 nMol/L were associated with obesity risk (OR 2.25[1.05-3.95], CI 95%) but not with risk of impaired glucose metabolism (1.07[0.54-2.12],CI95%). Our results showed that vitamin D insufficiency is highly prevalent in the population of healthy women. Low 25(OH)D levels correlated with high body fat, glucose levels and decreased insulin sensitivity. We conclude that vitamin D deficiency is a potential risk factor for obesity and development of insulin resistance leading to diabetes type 2.

[1]  J. Cauley,et al.  Associations between 25-hydroxyvitamin D and weight gain in elderly women. , 2012, Journal of women's health.

[2]  R. Luben,et al.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies , 2012, Diabetologia.

[3]  T. M. Ivashikina,et al.  [The detection of vitamin D3 deficiency in preschoolers and schoolchildren of Moscow and St. Petersburg]. , 2011, Klinicheskaia laboratornaia diagnostika.

[4]  Jennifer G. Robinson,et al.  Lack of Association Between 25(OH)D Levels and Incident Type 2 Diabetes in Older Women , 2011, Diabetes Care.

[5]  C. Rosen,et al.  Vitamin D and fat , 2011 .

[6]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women , 2010, Diabetes Care.

[7]  V. Freeman,et al.  Association of A1C Levels With Vitamin D Status in U.S. Adults , 2010, Diabetes Care.

[8]  Morton B. Brown,et al.  Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans , 2010, Diabetes Care.

[9]  J. Adams,et al.  Update in vitamin D. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  C. Drevon,et al.  Serum Vitamin D Concentration Does Not Predict Insulin Action or Secretion in European Subjects With the Metabolic Syndrome , 2010, Diabetes Care.

[11]  S. Heymsfield,et al.  Dual Energy X-Ray Absorptiometry Body Composition Reference Values from NHANES , 2009, PloS one.

[12]  Lawrence J Appel,et al.  Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population , 2009, Pediatrics.

[13]  D. Bikle.  Nonclassic actions of vitamin D. , 2009, The Journal of clinical endocrinology and metabolism.

[14]  G. Curhan,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension Among Young Women , 2008, Hypertension.

[15]  R. Heaney.  Vitamin D in health and disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[16]  E. Yetley.  Assessing the vitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[17]  X. Sun,et al.  1α, 25-Dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor , 2008, International Journal of Obesity.

[18]  D. V. von Mühlen,et al.  Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. , 2008, European journal of endocrinology.

[19]  S. Booth,et al.  Vitamin D3 in fat tissue , 2008, Endocrine.

[20]  S. Poppitt,et al.  Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity , 2008, Nutrition Journal.

[21]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[22]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[23]  E. Hyppönen,et al.  Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort , 2006, Diabetes Care.

[24]  M. Holick.  High prevalence of vitamin D inadequacy and implications for health. , 2006, Mayo Clinic proceedings.

[25]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[26]  G. McCabe,et al.  Parathyroid hormone is associated with decreased fat mass in young healthy women , 2006, International Journal of Obesity.

[27]  D. Yach,et al.  Epidemiologic and economic consequences of the global epidemics of obesity and diabetes , 2006, Nature Medicine.

[28]  P. Lips,et al.  Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia , 2005, Osteoporosis International.

[29]  S. Page.  Dietary Supplement Fact Sheet Vitamin D , 2005 .

[30]  E. Romagnoli,et al.  Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects , 2005, Osteoporosis International.

[31]  M. Saad,et al.  Hypovitaminosis D is associated with insulin resistance and β cell dysfunction , 2004 .

[32]  J. Yanovski,et al.  The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  J. Manson,et al.  The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. , 2004, Archives of internal medicine.

[34]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[35]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[36]  J. Aloia,et al.  Body fat content and 25-hydroxyvitamin D levels in healthy women. , 2003, The Journal of clinical endocrinology and metabolism.

[37]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[38]  N. Schneiderman,et al.  Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. , 2000, Diabetes research and clinical practice.

[39]  J. Manson,et al.  Obesity and mortality: a review of the epidemiologic data. , 1997, The American journal of clinical nutrition.

[40]  L. Lind,et al.  Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study. , 2009, Acta medica Scandinavica.

[41]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.